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Abstract
Background: The Prolapse Quality of Life (P-QoL) is a disease-specific instrument designed to measure the health-
related quality of life in women with prolapse; however, there is no Amharic version of the instrument. The aim of
this study were to translate the P-QoL into Amharic and evaluate its psychometric properties among adult women.
Methods: We followed an intercultural adaptation procedure to translate and adapt the P-QoL. A forward–
backward translation, face validity interviews with experts and cognitive debriefing of the translated version with
ten adults from the target group were performed. The Amharic version was then completed by 230 adult women
with and without POP symptoms. All women were examined using a simplified Pelvic Organ Prolapse
Quantification (SPOP-Q) system. We examined internal consistency (Cronbach’s alpha) and test–retest reliability
(intraclass correlation coefficient = ICC). Confirmatory factor analysis (CFA) was conducted and model fit was
discussed. We extracted a new factor structure by exploratory factor analysis (EFA). Criterion validity was also
assessed against the SPOP-Q stage.
Results: The translated measure was found acceptable by the experts and target group, with only minor adaptations
required for the Amharic context. It had high internal consistency (α = 0.96) and test–retest reliability (ICC = 0.87;
p < 0.001). In CFA results, the model fit indices were unacceptable (CFI = 0.69, RMSEA = 0.17, SRMR = 0.43, TLI = 0.65, and
PCLOSE = 0.00). EFA extracted three-factor with satisfactory convergent and discriminant validity. The P-QoL median
scores were significantly higher in symptomatic women (Mann-Whitney U Test; p < 0.001). The score was also
significantly correlated with stage of prolapse (Spearman’s correlation coefficient = 0.42 to 0.64, p< 0.001).
Conclusions: The P-QoL scale was successfully translated to Amharic and appears feasible, reliable and valid for Amharic-
speaking women. Factor analysis confirmed a three-factor structure, inconsistent with the original English version. Further
studies are needed to evaluate responsiveness of the Amharic P-QoL score.
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Background
Pelvic organ prolapse (POP) is the downward decent of
the female pelvic organs (vagina, uterus, bladder, and/or
rectum) into or through the vagina [1]. Globally around
20 to 50% of women suffer from POP [2, 3] and risk
increases with age, parity and heavy lifting [2, 4].
POP exhibit multiple symptoms [5] that negatively
impact women’s quality of life [6]. Health-related quality
of life (HRQOL) is a composite health outcome [7] imply-
ing several subsets of function: physical, psychosocial and
sexual [2, 8]. In low-income countries, women are exposed
to known and probable risk factors such as high fertility
rate, early childbirth, little access to treatment, limited and
poor obstetric care, considerable physical burdens and fi-
nally, socio-cultural beliefs that hinder to seeking medical
advice [4, 9, 10]. As a result POP might be more common,
generally more severe and disproportionally affect women’s
life in low-income [2, 9] compared to high-income coun-
tries. In Ethiopia, gynecological problems are important
health problems affecting maternal health outcomes [11]
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and studies have shown that 9.4 to 55.1% of women suffer
from POP [4, 12]. The country has almost all the risks
favorable for POP [4, 9, 10] and POP accounted for ~ 41%
of major gynecological operations in clinical setups [13].
Severity and impact of POP symptoms on HRQoL are
important outcome measure in the management of POP
as it reveal important aspects of the patient’s subjective
experience [6, 14]. To this end, measuring HRQoL re-
quires the use of a valid and reliable questionnaire. This
enables comparison of outcome measures and thereby
increases the accuracy of measurement [15]. Given the
growing use of HRQoL as a surrogate outcome measure,
there are considerable work in the development, adapta-
tion and translation of condition-specific instrument in
the field of Urogynecology [6]. For instance, a review by
Al-Badr [16], identified four instruments specifically
designed or adapted to evaluate HRQoL in women with
POP: the Pelvic Floor Distress Inventory (PFDI), the Pel-
vic Floor Impact Questionnaire (PFIQ) [17], the Prolapse
Quality of Life (P-QoL) [18] and the electronic Personal
Assessment Questionnaire Pelvic Floor (ePAQ-PF) [19].
The P-QoL, originally written in English, was devel-
oped in 2005 to measure severity of symptom and its
impact on the HRQoL [18]. The questionnaire contains
20 items that were grouped in 9 domains. The grouping
of questions in each domain was chosen because the ques-
tions related to a particular aspect of HRQoL [18]. It has
been translated to and validated in several language includ-
ing Turkish [20], Portuguese [21], German [22], Dutch
[23], Thai [24], Slovakian [25], Brazilian [26], Persian [27],
Spanish [28] and Afrikaans [29]. The initial validation and
subsequent cross-validations have assessed psychometric
properties (reliability, validity and responsiveness) and both
reported as a reliable and valid instrument [18, 20–29].
However, neither of the studies performed factor analysis
to identify or confirm the aforementioned domains. Even
in the absence of factor analysis, a 9-factor structure was
reported in the translated studies [20–23, 25–28].
Instrument measuring health status needs evaluation of
psychometric properties [30, 31] as the performance of an
instrument may differ between populations and in various
cultures [30]. Thus, the evaluation of any measure should be
conducted within the population and setting in which it is
going to be used. To our knowledge the psychometric prop-
erties of the P-QoL have not been evaluated in Amharic.
Amharic, the official working language in Ethiopia, is spoken
as the first language in the region where the study was
conducted [32]. The lack of a validated Amharic question-
naire investigating HRQoL in patients experiencing POP
limits studies and effective outcome measurement in
Amharic-speaking patients in Ethiopia. Therefore, this study
aimed to translate and adapt the P-QoL into Amharic and
test its psychometric properties (internal consistency, test–
retest reliability, content, construct, and criterion validity).
Methods
This cross-sectional study was conducted in two phases. In
phase I, translation and adaptation of the P-QoL from
English into Amharic were undertaken. In phase II, psycho-
metric validation of the Amharic version was performed.
The original P-QoL questionnaire
P-QoL is a specific, multidimensional questionnaire with
20 items/questions. All questions, except the first which
has five points, are assessed on a four-point scoring
system (0 = none/never, 1 = slightly/sometimes, 2 =mod-
erately/often, 3 = a lot/all the time). This scoring system
is not a Likert scale, which is based on the fact that the
intervals between two levels are all equal, i.e. the differ-
ence between ‘slightly’ and ‘moderately’ (equal to one
point) may not be the same as that between ‘moderately’
and ‘a lot’ (also equal to one point). As such, it is incor-
rect to compute as ordinal scale to determine subscale
scores. Thus, we considered items as continuous. The
items were attributed to 9 domains that were transformed
into a scale of 0 = (better HRQoL) excellent to 100 = (im-
paired HRQoL) poor: General Health Perception (GHP,
one item: 1), Prolapse Impact (PI, one item: 2), Role
Limitation (RL, two items: 3–4), Physical Limitation (PL,
two items: 5–6), Social Limitation (SL, two items: 7–8),
Personal Relationships (PR, three items: 9–11), Emotions
(E, three items: 12–14), Sleep/Energy (SE, two items:
15–16), and Severity Measurement (SM, four items:17–20).
Phase 1: Translation and adaptation of P-QoL into
Amharic
After obtaining permission from the developers, we
followed a standard procedure in five stages, according
to the established guidelines for translation and adapta-
tion: (1) forward translation, (2) synthesis of translations,
(3) back-translation, (4) consolidation of translations by
a committee of experts and (5) pre-test [33–35].
Stage 1- forward translation
Translation was performed by three (gynecologist, repro-
ductive health officer and English instructor) independent
native Amharic speakers fluent in English.
Stage 2- synthesis of the translations
A common Amharic version was created using the three
translated versions through consensus between the au-
thors and two other bilingual experts.
Stage 3- Back translation
The synthesis version created at the second stage was
used for back- translation process. Three translators
(different to stage 1) fluent in English and Amharic con-
ducted the back-translations independently. Both were
blinded and naïve to the English and translated version.
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The original and back-translated versions were checked
for discrepancies by the authors and then referred back
to the developers for conceptual and semantic equiva-
lence. Changes, if any, were incorporated and the first
Amharic version was produced.
Stage 4- expert committee review
An expert committee (n = 7) with medical, public health, al-
lied health science, and sociology backgrounds subsequently
reviewed the final forward and backward-translations.
Consultations were conducted in person and the
principal author (TB) coordinated this stage. Semantic,
idiomatic, experiential and conceptual equivalence of the
translated version were evaluated. Any issues raised were
addressed, and a preliminary version was created and cir-
culated among review members. Moreover, expert com-
mittee were asked to evaluate the suitability of each item
and rate its relevance. Agreement was then calculated
using Content Validity Index (CVI) [36]. Subsequently a
second Amharic version was produced.
Stage 5- pre-test
To evaluate the equivalence and comprehensibility of
the translated version, the second Amharic version was
face-validated and pretested. Ten women who had stage
3/4, aged 41–60 years, speak and understand Amharic
were included. An in-depth interview was conducted
with each participant by an experienced female sociolo-
gist after completing the Amharic P-QoL. The interview
aimed to identify the participants’ opinion on the ques-
tionnaire’s usability, applicability, and completeness. In
addition, they were asked about the difficulties in under-
standing the items and instructions, the misunderstanding
of words, the clarity of the response options and/or
whether the questionnaire missed any aspects of HRQoL.
Data were then discussed in the research team and deci-
sions were made whether changes in the questionnaire
were necessary. The interviews were conducted among
women admitted to a gynecology ward at the University
of Gondar Hospital where the psychometric testing was
planned. The length of the interview was on average 30
min, including questionnaire completion.
Phase 2: Psychometric validation of the Amharic P-QoL
questionnaire
Study participants
All women aged ≥18 years, with or without POP symp-
toms, willing to participate in the studyand who visit
the Gynecology Outpatient Clinic of the University of
Gondar Hospital between December 2017 and March
2018 were eligible for inclusion. However, women who
had a psychiatric problem, could not speak or under-
stand Amharic, had undergone previous POP surgery,
had a known or suspected pregnancy, were postpartum
(first 6 weeks following childbirth), had palpable pelvic
mass (uterine, ovarian, colorectal, bladder) or had his-
tory of acute symptoms of urinary tract infection were
excluded from the study.
Study participants were identified by one of the re-
search team (MA) before undergone symptom screening
and pelvic examination. Symptoms of POP were assessed
(MA) using two questions [4, 37]: Do you have a feeling
of bulging/pressure or something coming down through
the vagina? Do you have a visible mass protruding from
the vagina? If the participant had experienced one or
both of these problems in the past 1 year, they were
considered to have symptoms of POP and were defined
as symptomatic.
Sample size
Sample size was determined based on the recommenda-
tions of at least 5 to 10 subjects per item of the instrument
by the Consensus-based Standards for the Selection of
Health Measurement Instruments (COSMIN) [30]. To
this end, the minimum estimated sample was 200. But we
included 30 participants to protect against dropout and
missing responses. Then the final participants were 230.
Data collection
Patients were recruited consecutively and a two-stage
strategy was used to collect data. First, a face-to-face
interview was conducted by two female Midwifery
Nurses using the translated P-QoL at the outpatient visit
(baseline data). These data collectors were not involved
in pre-testing. After completing the questionnaire, all
women were asked to volunteer for a pelvic examin-
ation. One research team member (TG) blinded to the
questionnaire score performed the pelvic examination.
The simplified Pelvic Organ Prolapse Quantification
(S-POPQ) staging system was applied [38]. Pelvic exam-
ination was supervised by the research team gynaecolo-
gist (MA). Pelvic examination was done after the woman
emptied her bladder. After receiving an explanation of
the procedure, the participant was requested to lie on an
examination couch in the lithotomy position. A disarti-
culated Graves speculum was inserted into the vagina.
The posterior vaginal wall was retracted to observe the
descent of the anterior vaginal wall and the degree of
protrusion in relation to hymenal ring with strain or
cough. Secondly, the anterior vaginal wall was retracted
to observe a descent of the posterior vaginal wall during
straining. In accordance with the method, no measuring
device was used. The examiner estimated the degree of
descent by observing the points on the anterior and pos-
terior vaginal segments that were used to represent the
respective walls. The point descent in relation to the
hymenal ring while performing Valsalva or cough was
recorded as the stage in the three areas examined
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(anterior, posterior and apical/cervix) and the final stage
was the maximum one from the three measurements.
Accordingly, women were assigned a SPOPQ stage as:
stage 0, no prolapse; stage 1, leading point of the wall of
the vagina or cervix remains at least 1 cm above the hy-
menal ring; stage 2, leading point descends to the introi-
tus, defined as an area extending from 1 cm above to 1
cm below the hymenal ring; stage 3, leading point
descends > 1 cm outside the hymenal ring, but does not
form a complete vaginal vault eversion or procidentia
uteri, and stage 4, complete vaginal vault eversion or
procidentia uteri [38].
To measure the test–retest reliability, a randomly
selected patients (n = 70) were asked to complete the
questionnaire 2 weeks later. Patients were selected at
random for to maximize the probability that the patients
who received the questionnaire were representative of
the sample population. The follow-up assessment was
performed with face-to-face interviews by same data col-
lectors who collected the baseline. Stability was evalu-
ated by Patient Global Impression of Change (PGIC)
scale [39] using the above data collectors. The PGIC
evaluates overall health status as perceived by the patient
in a seven-point single-item scale ranging from ‘very
much worse’ to ‘very much improved’. For descriptive
purposes, patients were classified into three categories
according to the PGIC score: disease deterioration (very
much worse, much worse and minimally worse), stable
disease (no change) or disease improvement (very much
improved, much improved and minimally improved)
since the initial baseline visit. Women were considered
stable if she rate “no change” on the PGIC scale [40].
The PGIC have been implemented and/or validated in
clinical studies of patients with urogenital prolapse [41].
The questionnaire was translated from English to Am-
haric without back-translation before use. In this study
women were considered stable if she scored “no change
or almost the same” on the scale.
Statistical analysis
Sociodemographic characteristics and selected clinical
background information were described with descriptive
statistics. The responses were checked for completeness
and partly completed questionnaires were removed prior
to analysis. When necessary, items were recoded and
transformed [18]. Semantic, idiomatic, experiential and
conceptual equivalences were evaluated using content
and face validity and acceptability. However, measure-
ment equivalence was evaluated with test-retest reliabil-
ity, internal consistency, and construct and criterion
validity based on the COSMIN recommendations [42].
The significance level was set as 0.05.
Content validity, whether all domains of the P-QoL
would cover all the appropriate domains of HRQoL, was
evaluated. Questionnaires that demonstrate content val-
idity should have few missing responses, use the full
range of scores with little skew, and have few ceiling
(best possible score) or floor (poorest possible score) ef-
fects. Face validity, the extent to which a questionnaire
is a logical measure of what it intends to measure in the
opinion of the experts and patients [43], was evaluated
by the expert committee throughout the adaptation
process and the pre-test through qualitative analysis of
the comments provided. The experts were asked to
make remarks or comments on the plausibility of the
questions, the comprehensiveness, and the relevance of
a scale ranging from 1 to 4 (very relevant to irrelevant).
Expert agreement on relevance was calculated using the
CVI, and agreement ≥80% was considered acceptable [36].
Moreover, acceptability, the extent to which an instru-
ment is acceptable to participants, was evaluated using the
estimated time required to fill out the questionnaire, per-
centage of fully completed questionnaire, percentage of
difficult/distressing item, and levels of missing data [44].
Reliability was assessed using agreement and consistency
indices. Cronbach’s alpha was computed to assess the in-
ternal consistency of subscale and items in the P-QoL ques-
tionnaire, and values of ≥0.7 were considered adequate [30].
We further analyzed item-to-subscale and item-to-total
correlations to evaluate the fit of the item within the sub-
scale and the total score. Item-total correlations of ≥0.5 and
interitem correlations ≥0.3 were considered acceptable [45].
We hypothesized that individual items or indicators of the
scale should all be measuring the same construct and thus
be highly inter-correlated. The interclass correlation coeffi-
cients (ICC 2, 1; two observation time points of one item)
was calculated in order to evaluate the reproducibility of the
results (under constant condition). Single rating, absolute
agreement, and a two-way mixed- effects model were used.
We assumed that item scores of the two test results would
be in agreement and ICC value ≥0.7 were satisfactory [42].
Construct validity was evaluated by factorial (ex-
ploratory and confirmatory factor analysis, discrimin-
ant and convergent validity) and known group validity
(hypothesis testing) [46].
Exploratory factor analysis (EFA) is known as a data-
driven method, and confirmatory factor analysis (CFA) as
a theory-driven method. So the usage of EFA or CFA
should be strictly considered and chosen according to the
aim of a study, and aimless application of EFA and CFA to
the same dataset should be avoided [47]. Latent variable
structure of a dataset can be explored with EFA. On the
other hand, CFA requires an a priori hypothesis or previ-
ous “theory” as CFA is a hypothesis testing method which
tests whether the obtained dataset is suitable for a model
[47]. Thus, first we used CFA to investigate whether the
9-factor structure can be replicated in the new dataset
(model fit of the dataset obtained from 212 participants).
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CFA with maximum likelihood estimation was used for
validation [48, 49]. The following goodness-of-fit indi-
ces were used to assess the model: Tucker Lewis Index
(TLI; > 0.90 acceptable, > 0.95 excellent), the Compara-
tive Fit Index (CFI; > 0.90 acceptable, > 0.95 excellent),
and Root Mean Square Error of Approximation (RMSEA;
< 0.08 acceptable, < 0.05 excellent), and Standardized Root
Mean Residual (SRMR; < 0.08 acceptable) [50]. Second,
after performing CFA, we extracted a more suitable factor
structure from the same dataset. We then performed ex-
ploratory factor analysis (EFA) [48, 51]. Since our sample
data violated the assumption of multivariate normality,
EFA was performed using Principal axis factoring (PAF)
extraction method [48, 49]. Extracted factors were rotated
by oblique (promax) rotation [52]. Oblique rotation was
chosen based on the expectation that dimensions of health
would be associated [53]. Prior to conducting EFA,
Bartlett’s test of sphericity (p < 0.05) [54] and the Kaiser–
Meyer–Olkin (KMO > 0.5) measure of sampling adequacy
[55] was performed to evaluate the factorability. The
determination of the number of meaningful factors to be
retained was guided by the scree plot test (above the
break or elbow), Kaiser’s criteria (Eigenvalue≥1), in-
terpretability, and the cumulative variance explained
(> 40%) [56]. Items of the P-QoL were retained based
on the following criteria: those with primary factor
loadings > 0.4 and secondary factor loadings < 0.3
[51]. Items that did not meet these criteria were in-
dividually removed and the EFA repeated until all
remaining items met these criteria for item retention. The
reliability of items in each factors was examined using
Cronbach’s alpha and value ≥0.7 for a factor was deemed
reliable [30]. We also evaluated convergent and discrimin-
ant validity for the extracted factors. Factor-based conver-
gent validity, the degree to which items within a single
factor are highly correlated, was measured by compos-
ite reliability (CR ≥0.7) and average variance extracted
(AVE ≥0.5) [57]. AVE < CR was used to establish con-
vergent validity [58]. Factor-based discriminant validity,
the extent to which factors are distinct and uncorrelated,
was assessed by comparing AVE, maximum shared
squared variance (MSV), average shared squared variance
(ASV) and square root of AVE [59]. Discriminant validity
was corroborated if AVE >MSV/ASV and the AVE square
root of a given factor greater than inter-construct correl-
ation [57]. Model validity measures was performed using
“master Validity Tool”, AMOS Plugin [60].
Known group validity was evaluated by comparing the
median-score distribution of P-QoL factors according to
symptom status of participants. Women having POP
symptoms are associated with poor HRQoL [18, 28].
Therefore, we tested the hypothesis that women with
symptoms suggestive of POP would had a lower HRQoL
scores as compared with those without symptoms of
POP. The participants of this study were divided into
two groups based on the symptom status (symptomatic
vs. asymptomatic). Median P-QoL score of the two
groups were tested using Mann-Whitney U test since
our P-QoL score did not follow a normal distribution.
Criterion validity, how well the questionnaire corre-
lates with an existing gold standard, was assessed by
comparing P-QoL factors scores with the objective vagi-
nal examination findings using SPOP-Q system [18].
Spearman’s correlation coefficient (SCC) was used to
quantify the magnitude of the correlation. We used the
following criteria to interpret the size of the correlation
coefficients: 0.8–1.0 excellent, 0.61–0.80 very good,
0.41–0.60 good, 0.21–0.40 sufficient, and 0.00–0.20 poor
[61]. We hypothesized that P-QoL score is correlated
with SPOP-Q score and women with higher score of
SPOP-Q had poor HRQoL.
We used the Analysis of Moment Structures (AMOS;
version 23, Chicago, IL) for CFA, the Statistical Package for
Social Sciences (SPSS; version 20, IBM Corp., Armonk, NY)
for EFA, and STATA version 14 (StataCorp, College
Station, TX, USA) for other calculations.
Ethical approval
Prior to study commencement, the developers’ authorization
for the adaptation was obtained. Participation in the study
was voluntary, and verbal and/or informed written consent
was obtained prior to inclusion. The study was approved by
the Institutional Review Committee at the University of
Gondar (O/V/P/RCS/05/216/2017 on November 2017).
Results
Characteristics of participants
Of the 230 women invited to take part in the validation
procedure, seven were excluded due to withdrawal be-
fore pelvic examination (n = 4) or were missing after
completion of the interview (n = 3). In total, 223 women
were enrolled in the final analysis, giving a response rate
of 97%. Among these 223 participants, 152 (68.2%) were
classified as symptomatic, and 71 (31.8%) as asymptom-
atic. The mean age and parity were 46.5 years (range 20
to 70) and 5.8 (range 0–12) respectively. Symptomatic
women were older and had higher parity than asymp-
tomatic women (p < 0.001). There were 139 symptom-
atic women (91.4%) in POP stage 3 or 4. However, 37
(52.1%) of asymptomatic women had no POP and none
of them had more than stage 2. The characteristics of
the study participants are presented in Table 1.
Translation and adaptation of P-QoL scale
Stage 1- Forward translation was performed as planned
without major difficulty. However, specific challenge re-
lated to the idiomatic usage of the word “prolapse” was
found. It had several translation alternatives and required
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consideration by the committee of experts to reach a con-
sensus to ensure semantic and idiomatic equivalence.
Stage 2- Principal investigator (TB) and other two bilin-
gual experts prepared the synthesis version with the aid of
both Amharic versions.
Stage 3- Backward translation was carried out as
planned. Both backward translated versions were com-
pared with the original and satisfactory similarity was
noted. Since no changes were introduced by the original
developer, this version was used for pre-testing.
Stage 4- This stage was also performed as planned and
no major problem encountered. By considering the is-
sues raised in the forward translation process (stage 1),
panel of experts agreed to replace the “prolapse” with
the meaning of “uterine prolapse”.
Stage 5- The following difficulties were encountered in
pre-testing. Seven patient had difficulty in understanding
the word ‘prolapse’. Hence, an optional word inside the
bracket ‘a protrusion of womb or uterus’ was added to
make this question comprehensible. The revised question
read as ‘prolapse/protrusion of uterus/womb’ and asked to
the same patients, and responded well to it. Due to cul-
tural taboos prevalent in Ethiopia, women feel uncomfort-
able in talking about sexual behavior. Similar observation
is noted while patients were asked to respond to questions
found in PR domains (item 9 and 10). Patients initially felt
hesitation in responding; however, on explaining, they
could realize the importance of such questions and an-
swered appropriately.
Comments were analyzed by the committee of experts.
After judging the comments made by participants during
the pre-test, and resolved by consensus, the committee
of experts drafted the final translated version of P-QoL
and adopted for use in the psychometric evaluation. The
final Amharic version of the P-QoL questionnaire is
shown in the “Additional file 1”.
Acceptability
All participants responded to all items in the Amharic
P-QoL questionnaire, and marked legibly and correctly
(no missing items found). Data collectors reported no dif-
ficulties in asking the items and no patients reported hav-
ing met problems in understanding the items. The average
time taken to complete the questionnaire was 6min.
Content validity
Content validity was considered adequate according to the
criteria and the arguments made by the committee of
experts during the process of adaptation and the qualita-
tive analysis of participant/women comments. All of them
agreed on all of the proposed translated items as accept-
able. The average scale content validity (CVI) was 0.98,
which is above the cut-off of 0.80. No changes, including
relevant items that need to be added, were made to the
items as result of the content validity review. Participant
interviewees reported that in general the items in the
questionnaire were clear and comprehensible achieving
face validity. However, they suggested a few changes when
drafting a final version of the instrument.
Evaluation of psychometric properties
Reliability and item analysis
Internal consistency of the translated version was 0.96
[95% confidence interval (CI)] 0.95–0.97; p < 0.001).
The average interitem correlation was 0.55 with the
individual correlations ranging from 0.23 to 0.88, sug-
gesting good reliability. The average item- total correl-
ation was 0.68. The correlations between the 20 items of
the P-QoL and the total scores ranged from 0.49 to 0.88,
indicating good relationship between each item and all
the other items on the scale. As seen in Table 2, the
magnitude of change in Cronbach’s alpha was almost
uniform across items, and in no instances did removal of
an item from the scale result in an increase in the value
of Cronbach’s alpha.
Ten women reported a change in POP severity and
were removed from the test-retest analysis. The sec-
ond test was performed with a median of 12 days
(range 8–21 days) after baseline. The result revealed
excellent test-retest reliability between the paired
scores for all the domains (ICC = 0.87 [95% confi-
dence interval (CI)] 0.82–0.92; p < 0.001).
Table 1 Characteristics of study participants, University of







Mean(+SD) 50.3 (11.3) 38.8 (13.6) < 0.001a
Educational status*
Illiterate 149 (98.0) 62 (87.2)
Literate 3 (2.0) 9 (12.8)
Parity
Mean(+SD) 6.7 (2.7) 3.9 (3.3) < 0.001a
POP-Q findings, n (%)
Stage 0 0 (0) 37 (52.1)
Stage 1 4 (2.6) 27 (38.0)
Stage 2 9 (5.9) 7 (9.9)
Stage 3 113 (74.3) 0 (0)
Stage 4 26 (17.1) 0 (0)
Total 152 (100%) 71 (100%)
SD standard deviation, POP-Q Pelvic Organ Prolapse Quantification system
*Literate participants attended formal education at primary, secondary,
preparatory or/and university/college level; illiterate participants did not attend
formal education and include those who could and could not read and write
aCalculated with independent t-test
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Confirmatory factor analysis
The hypothesized 9-factor model had inadequate fitness
indicators (CFI = 0.69, RMSEA = 0.17, SRMR = 0.43,
and TLI = 0.65).
Exploratory factor analysis
The KMO measure of sampling adequacy was 0.95 and
the significance of Bartlett’s test of sphericity was less
than 0.001 (χ2 = 4086.55, df = 190), meaning that EFA
can be applied to the obtained dataset. A total of three
factors were extracted and rotated, and the cumulative
variance explained was 70.01%. Factor loadings indicate
that individual item reliability was adequate for all items,
ranging from 0.50 to 0.95 for the three factor model.
Twelve items, i.e., from #1 to #8, and #17 to #20, were
entered with item loadings ranging from 0.47 to 1.03 in
Factor 1, which was designated physical function. Five
items (#12, #13, #14, #15, and #16) were entered for Fac-
tor 2, which was designated psychological function.
Three items (#9, #10, and #11) were entered for Factor 3,
which was designated social/personal relationship. Cronbach
alpha was greater than 0.85 in all factors. Average variance
extracted and Composite reliability showed adequate values.
The result demonstrated AVE > 0.5, AVE <CR and CR > 0.7
in all factors, indicating convergent validity of the ex-
tracted construct. Similarly, both extracted factors
were distinct showing divergent validity. AVE was
greater than MSV and ASV, and square root AVE was
greater than inter-construct correlation. EFA with fac-
tor loading of items is shown in Table 3.
Known group validity
There were statistically significant differences among
the two groups in the P-QoL scores (Mann-Whitney U
test; p < 0.001). The median P-QoL domain scores were
higher in symptomatic women compared to asymptomatic
showing a worse HRQoL in the former group (Table 4).
Criterion validity
Spearman’s correlation coefficients between extracted
P-QoL domain score and the SPOP-Q scores were from
0.42 and 0.64, indicating a low to moderate strength of
association. Both correlation coefficients were significant
at p < 0.001(Table 5).
Discussion
Summary of main findings
Like other diagnostic procedures, HRQoL measures should
be valid, reliable, and sensitive over time [62]. P-QoL has
proven to be valid and reliable instrument for assessment
and management of women with POP symptoms in
clinical and research practice [6, 14, 15]. Until now, their
Amharic translation has never been validated. In the
present study P-QoL questionnaire was translated in
Amharic and its reliability and validity were assessed.
The P-QoL scale was successfully translated and cul-
turally adapted to Amharic. The pilot study showed that
it worked well, although some minor changes had to be
made in finalizing the local language version to increase
its technical equivalence. The Amharic version demon-
strated excellent reliability and construct validity. Internal
consistency was very high and satisfactory agreement was
observed between the paired test-retest scores. With
regard to the overall score, ICC values were between 0.82
and 0.92 which is indicative of very good to excellent
agreement.
Based on CFA indices, this sample has unacceptable fit
to the 9-factor model. EFA found a 3-factor structure
model from the dataset. In EFA, communalities and factor
loadings for all the items were well above the cutoff
values. All extracted factors showed good discriminant
and convergent validity. We observed good correlations
between P-QoL and SPOP-Q scores. The Amharic version
Table 2 Internal consistency, item-total correlations, and alpha
if item deleted from the Amharic Pelvic Organ Prolapse Quality
of Life (P-QoL) questionnaire




1 Present general health 0.65 0.96
2 Prolapse impact on life 0.79 0.95
3 Impact on Household or role 0.83 0.95
4 Impact on activities outside
the home
0.80 0.95
5 Impact on physical activities 0.84 0.96
6 Impact on travel ability 0.86 0.96
7 Limit social life/activities/
work
0.88 0.94
8 Limit ability to visit friends/
families
0.85 0.94
9 Affect relationship with
partner/spouse
0.71 0.95
10 Affect sexual life with spouse 0.66 0.96
11 Affect family life 0.60 0.96
12 Feel depressed 0.78 0.95
13 Feel anxious/nervous 0.71 0.95
14 Feel bad about yourself 0.64 0.96
15 Affect sleep/bad dreams 0.60 0.96
16 Feel worn-out/tired 0.62 0.96
17 Use pad to protect 0.49 0.96
18 Manually push up 0.69 0.95
19 Pain/discomfort 0.73 0.95




Standardized item alpha 0.96
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was capable of detecting the difference of P-QoL score
between symptomatic and asymptomatic groups.
Translation and adaptation
The cross-cultural adaptation was performed using a
systematic approach [33], including different steps. Both
forward-and-backward translations were performed as
planned and there were no changes in the instruction, and
lay-out of the questionnaire. But selected items proved
difficult to translate and were changed. All changes had
the purpose to optimize the comprehensibility of the
questionnaire and were discussed with the members of
the research team. Although difficulties were encountered
during pre-testing, especially in understanding some ter-
minology, the result suggest the Amharic version of the
P-QoL has good acceptability. The absence of difficulty in
Table 3 Exploratory factor analysis with factor loadings for the Amharic Pelvic Organ Prolapse Quality of Life (P-QoL) questionnaire
Items Item description Factor 1 Factor 2 Factor 3
Item 1 Present general health (GHP) 0.56 0.12 0.02
Item 2 Prolapse impact on life (PI) 0.85 0.00 0.02
Item 3 Impact on Household or role (RL1) 1.03 −0.11 − 0.01
Item 4 Impact on activities outside the home (RL2) 1.03 −0.13 −0.03
Item 5 Impact on physical activities (PL1) 0.84 0.04 0.06
Item 6 Impact on travel ability (PL2) 0.84 0.11 −0.01
Item 7 Limit social life/activities/work (SL1) 0.78 0.15 0.05
Item 8 Limit ability to visit friends/families (SL2) 0.69 0.12 0.15
Item 9 Affect relationship with partner/spouse (PR1) 0.07 0.03 0.81
Item 10 Affect sexual life with spouse (PR1) −0.09 −0.03 1.02
Item 11 Affect family life (PR3) 0.17 0.07 0.49
Item 12 Feel depressed (E1) 0.14 0.74 0.07
Item 13 Feel anxious/nervous (E2) −0.05 0.99 −0.05
Item 14 Feel bad about yourself (E3) −0.06 0.78 0.07
Item 15 Affect sleep/bad dreams (SE1) 0.27 0.64 −0.04
Item 16 Feel worn-out/tired (SE2) 0.03 0.44 0.00
Item 17 Use pad to protect (SM1) 0.49 0.09 −0.06
Item 18 Manually push up (SM2) 0.59 0.12 0.03
Item 19 Pain/discomfort (SM3) 0.47 0.34 0.00
Item 20 Prevent standing (SM4) 0.52 0.30 0.04
Cronbach’ alpha 0.96 0.87 0.86
Average variance extracted (AVE) 0.56 0.55 0.65
Composite reliability (CR) 0.92 0.85 0.84
Maximum shared squared variance (MSV) 0.50 0.50 0.45
Average shared squared variance (ASV) 0.48 0.44 0.41
Square root of AVE (√AVE) 0.74 0.74 0.80
Items with high loading (> 0.4) to factors are indicated in bold
Extraction Method: Principal Axis Factoring
Rotation Method: Promax with Kaiser Normalization
Table 4 Comparison of the Amharic Pelvic Organ Prolapse Quality of Life (P-QoL) domain scores between symptomatic and
asymptomatic women







Physical function (Factor 1) 75 (83, 64) 36 (52, 22) 1423 < 0.0001
Psychological function (Factor 2) 67 (80, 53) 40 (60,13) 2857 < 0.0001
Social/personal relationship (Factor 3) 67 (78,44) 22 (44,0) 2212 < 0.0001
a Calculated using the Mann–Whitney test
Interquartile ranges (IQR)
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responding the majority of items, the ease of completion
within short period of time, and appropriately responding
to those difficult but revised questions provides evidence
for the acceptability of the instrument.
Content validity was determined in a similar way as
described by previous validation studies of the P-QoL [28,
29]. Emphasis was given to maintain the original context
and meaning of the words rather than a direct word by
word translation [42]. We found the Amharic questionnaire
as content valid after excellent expert panel agreement on
the relevance of items [36] and reviewed by multilingual
expert translators. Moreover, it appears acceptable to pa-
tients and does not constitute an extra burden to the pro-
fessionals using it. We concur with other investigators that
the P-QoL is easy to use in a busy clinical setting [18, 22].
Reliability
In this study, the Amharic version of P-QoL demon-
strated excellent internal consistency (0.96). This finding
was comparable to other studies which demonstrated a
Cronbach’s alpha scores of between 0.84 and 0.93 [18,
24, 27, 63] and considerably higher than the traditional
threshold of 0.7 [30], indicating inter correlation of the
items found in the instrument. Average interitem correl-
ation and average item-total correlation were also high,
suggesting good reliability of the instrument. These high
internal reliability of the instrument may be sufficient
for individual clinical use as well as use for research
groups, according to Bland and Altman [64].
The 2-week test–retest reliability result also demon-
strated excellent correlation between paired test–retest
scores (ICC for agreement 0.87; p < 0.001). The duration
was chosen because it is long enough to avoid recall bias
and short enough for the condition to stay unchanged
[18, 42]. The result is comparable with the English
(0.64–0.83) [18], Persian (0.76–0.95) [27] and Dutch
(0.89–0.99) [23] validation studies, ensuring that re-
sponses are not too varied across time periods. So meas-
urement taken at any point in time using the Amharic
P-QoL is reliable. This may encourage researchers in the
future to interpret their results from the Amharic version.
Validity
In this study, CFA result showed unacceptable model fit
to the 9-factor model. Also, we conducted EFA to extract
the new factor structure of the dataset and found a
three-factor structure model. However, this factor struc-
ture is inconsistent with the factor structure reported in
the original English version [18] and other validation stud-
ies [25, 27, 28]. But as to the construct validity, current
study strongly supported the multidimensionality of
the scale and corroborate with the existing literature
[18, 23, 24]. All of the extracted factors showed ac-
ceptable Cronbach alpha and demonstrated good conver-
gent and divergent validity. Moreover, median P-QoL
domain scores were significantly higher in the symptom-
atic women compared to asymptomatic women (known
group validity). And this pattern of P-QoL scores observed
among groups suggests that the questionnaire is useful
for assessing HRQoL in women with POP symptoms.
The good discrimination ability of the Amharic meas-
ure among groups supports its high construct validity.
The correlation between the Amharic P-QoL score with
SPOP-Q stage were calculated for criterion (concurrent)
validity. Although there is no gold standard to determine
HRQoL in women with POP [42], SPOP-Q score was
taken as a reference standard [18, 28, 64] and evidence
showed a strong correlation between P-QoL and POP-Q
stage [18, 27, 65]. In this study we observed good cor-
relation between P-QoL and SPOP-Q scores (p < 0.001),
indicating a higher stage associated significantly with
worse P-QoL scores, especially in women with symp-
tom suggestive of POP. The correlation between scores
and vaginal finding in other studies [18, 23, 27] was
almost similar to our study, though they differ in
strength of correlation. Exhibiting correlation with the
stage of POP doesn’t mean P-QoL assessment substi-
tute or replace physical examination.
Strengths of this study are the adoption of a multistep
translation method, as supported by existing evidence ra-
ther than the simple translation/back-translation process
[33, 34], and used COSMIN recommendations for report-
ing of measurement properties [46], which is the current
reference standard for reporting measurement properties
as proposed by Terwee et al. [30]. Specific limitations,
however, must considered when interpreting this findings.
First, our study was conducted in a single urban hospital;
therefore, results may not be generalizable to populations
in rural and remote areas. Specifically, rates of illiteracy
may impact validity. Further validation studies in more
general contexts are therefore recommended. Second, re-
sponsiveness to change and minimal clinically important
difference (MCID) were not evaluated because of logis-
tics problems. Since these are an important scale prop-
erty to determine the utility of the Amharic P-QoL
scales as outcome measures, we recommend inclusion
of this in future studies. Third, since there were no vali-
dated questionnaires in the Amharic language, we failed
to use other criterion comparators for both P-QoL item
Table 5 Spearman’s correlation coefficient (SCC) between the
Amharic Pelvic Organ Prolapse Quality of Life (P-QoL) domain scores
and vaginal examination (SPOP-Q stage) in symptomatic women
P-QoL Domains SCC P-value*
Physical function (Factor 1) 0.64 < 0.0001
Psychological function (Factor 2) 0.42 < 0.0001
Social/personal relationship (Factor 3) 0.51 < 0.0001
*Calculated using Spearman’s rank correlation (SCC) analysis
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and domain values. We used the SPOP-Q stage as a
gold standard criterion. Fourth, sensitivity of the topic
being studied carries the risk of providing socially desir-
able answers instead of true responses.
Conclusions
The P-QoL was successfully translated and culturally
adapted into Amharic. The Amharic version achieved good
conceptual and content equivalence. The translated version
was valid and reliable measure to assess POP symptom se-
verity and its impact on HRQoL in Amharic-speaking
Ethiopian women at the outpatient health care setting. The
questionnaire is easily understandable, and can be ad-
ministered and completed by patients and used in
clinical practice. Further studies are needed to evaluate
responsiveness of P-QoL.
Additional file
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kb)
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